The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global General Anaesthesia Drugs Market Research Report 2024
Synopsis
General Anaesthesia Drugs act on the central nervous system, inducing a sedative state in patients who are to go through a surgical procedure.
The global General Anaesthesia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for General Anaesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anaesthesia Drugs.
Report Scope
The General Anaesthesia Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global General Anaesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the General Anaesthesia Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter International
AstraZeneca
Abbott Laboratories
Roche
Fresenius
Mylan
Eisai
Hospira
Hikma Pharmaceuticals
Segment by Type
Propofol
Sevoflurane
Isoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of General Anaesthesia Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
General Anaesthesia Drugs act on the central nervous system, inducing a sedative state in patients who are to go through a surgical procedure.
The global General Anaesthesia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for General Anaesthesia Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Anaesthesia Drugs.
Report Scope
The General Anaesthesia Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global General Anaesthesia Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the General Anaesthesia Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Baxter International
AstraZeneca
Abbott Laboratories
Roche
Fresenius
Mylan
Eisai
Hospira
Hikma Pharmaceuticals
Segment by Type
Propofol
Sevoflurane
Isoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of General Anaesthesia Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Anaesthesia Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Isoflurane
1.2.5 Dexmedetomidine
1.2.6 Desflurane
1.2.7 Remifentanil
1.2.8 Midazolam
1.2.9 Others
1.3 Market by Application
1.3.1 Global General Anaesthesia Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global General Anaesthesia Drugs Market Perspective (2019-2030)
2.2 General Anaesthesia Drugs Growth Trends by Region
2.2.1 Global General Anaesthesia Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 General Anaesthesia Drugs Historic Market Size by Region (2019-2024)
2.2.3 General Anaesthesia Drugs Forecasted Market Size by Region (2025-2030)
2.3 General Anaesthesia Drugs Market Dynamics
2.3.1 General Anaesthesia Drugs Industry Trends
2.3.2 General Anaesthesia Drugs Market Drivers
2.3.3 General Anaesthesia Drugs Market Challenges
2.3.4 General Anaesthesia Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Anaesthesia Drugs Players by Revenue
3.1.1 Global Top General Anaesthesia Drugs Players by Revenue (2019-2024)
3.1.2 Global General Anaesthesia Drugs Revenue Market Share by Players (2019-2024)
3.2 Global General Anaesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Anaesthesia Drugs Revenue
3.4 Global General Anaesthesia Drugs Market Concentration Ratio
3.4.1 Global General Anaesthesia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Anaesthesia Drugs Revenue in 2023
3.5 General Anaesthesia Drugs Key Players Head office and Area Served
3.6 Key Players General Anaesthesia Drugs Product Solution and Service
3.7 Date of Enter into General Anaesthesia Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Anaesthesia Drugs Breakdown Data by Type
4.1 Global General Anaesthesia Drugs Historic Market Size by Type (2019-2024)
4.2 Global General Anaesthesia Drugs Forecasted Market Size by Type (2025-2030)
5 General Anaesthesia Drugs Breakdown Data by Application
5.1 Global General Anaesthesia Drugs Historic Market Size by Application (2019-2024)
5.2 Global General Anaesthesia Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America General Anaesthesia Drugs Market Size (2019-2030)
6.2 North America General Anaesthesia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America General Anaesthesia Drugs Market Size by Country (2019-2024)
6.4 North America General Anaesthesia Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe General Anaesthesia Drugs Market Size (2019-2030)
7.2 Europe General Anaesthesia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe General Anaesthesia Drugs Market Size by Country (2019-2024)
7.4 Europe General Anaesthesia Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Anaesthesia Drugs Market Size (2019-2030)
8.2 Asia-Pacific General Anaesthesia Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific General Anaesthesia Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific General Anaesthesia Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America General Anaesthesia Drugs Market Size (2019-2030)
9.2 Latin America General Anaesthesia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America General Anaesthesia Drugs Market Size by Country (2019-2024)
9.4 Latin America General Anaesthesia Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Anaesthesia Drugs Market Size (2019-2030)
10.2 Middle East & Africa General Anaesthesia Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa General Anaesthesia Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa General Anaesthesia Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter International
11.1.1 Baxter International Company Detail
11.1.2 Baxter International Business Overview
11.1.3 Baxter International General Anaesthesia Drugs Introduction
11.1.4 Baxter International Revenue in General Anaesthesia Drugs Business (2019-2024)
11.1.5 Baxter International Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca General Anaesthesia Drugs Introduction
11.2.4 AstraZeneca Revenue in General Anaesthesia Drugs Business (2019-2024)
11.2.5 AstraZeneca Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories General Anaesthesia Drugs Introduction
11.3.4 Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche General Anaesthesia Drugs Introduction
11.4.4 Roche Revenue in General Anaesthesia Drugs Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Fresenius
11.5.1 Fresenius Company Detail
11.5.2 Fresenius Business Overview
11.5.3 Fresenius General Anaesthesia Drugs Introduction
11.5.4 Fresenius Revenue in General Anaesthesia Drugs Business (2019-2024)
11.5.5 Fresenius Recent Development
11.6 Mylan
11.6.1 Mylan Company Detail
11.6.2 Mylan Business Overview
11.6.3 Mylan General Anaesthesia Drugs Introduction
11.6.4 Mylan Revenue in General Anaesthesia Drugs Business (2019-2024)
11.6.5 Mylan Recent Development
11.7 Eisai
11.7.1 Eisai Company Detail
11.7.2 Eisai Business Overview
11.7.3 Eisai General Anaesthesia Drugs Introduction
11.7.4 Eisai Revenue in General Anaesthesia Drugs Business (2019-2024)
11.7.5 Eisai Recent Development
11.8 Hospira
11.8.1 Hospira Company Detail
11.8.2 Hospira Business Overview
11.8.3 Hospira General Anaesthesia Drugs Introduction
11.8.4 Hospira Revenue in General Anaesthesia Drugs Business (2019-2024)
11.8.5 Hospira Recent Development
11.9 Hikma Pharmaceuticals
11.9.1 Hikma Pharmaceuticals Company Detail
11.9.2 Hikma Pharmaceuticals Business Overview
11.9.3 Hikma Pharmaceuticals General Anaesthesia Drugs Introduction
11.9.4 Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2019-2024)
11.9.5 Hikma Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global General Anaesthesia Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Propofol
Table 3. Key Players of Sevoflurane
Table 4. Key Players of Isoflurane
Table 5. Key Players of Dexmedetomidine
Table 6. Key Players of Desflurane
Table 7. Key Players of Remifentanil
Table 8. Key Players of Midazolam
Table 9. Key Players of Others
Table 10. Global General Anaesthesia Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global General Anaesthesia Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global General Anaesthesia Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global General Anaesthesia Drugs Market Share by Region (2019-2024)
Table 14. Global General Anaesthesia Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global General Anaesthesia Drugs Market Share by Region (2025-2030)
Table 16. General Anaesthesia Drugs Market Trends
Table 17. General Anaesthesia Drugs Market Drivers
Table 18. General Anaesthesia Drugs Market Challenges
Table 19. General Anaesthesia Drugs Market Restraints
Table 20. Global General Anaesthesia Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 21. Global General Anaesthesia Drugs Market Share by Players (2019-2024)
Table 22. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthesia Drugs as of 2023)
Table 23. Ranking of Global Top General Anaesthesia Drugs Companies by Revenue (US$ Million) in 2023
Table 24. Global 5 Largest Players Market Share by General Anaesthesia Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players General Anaesthesia Drugs Product Solution and Service
Table 27. Date of Enter into General Anaesthesia Drugs Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global General Anaesthesia Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 30. Global General Anaesthesia Drugs Revenue Market Share by Type (2019-2024)
Table 31. Global General Anaesthesia Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 32. Global General Anaesthesia Drugs Revenue Market Share by Type (2025-2030)
Table 33. Global General Anaesthesia Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 34. Global General Anaesthesia Drugs Revenue Market Share by Application (2019-2024)
Table 35. Global General Anaesthesia Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 36. Global General Anaesthesia Drugs Revenue Market Share by Application (2025-2030)
Table 37. North America General Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America General Anaesthesia Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America General Anaesthesia Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe General Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Europe General Anaesthesia Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 42. Europe General Anaesthesia Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 43. Asia-Pacific General Anaesthesia Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 44. Asia-Pacific General Anaesthesia Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 45. Asia-Pacific General Anaesthesia Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 46. Latin America General Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Latin America General Anaesthesia Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 48. Latin America General Anaesthesia Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 49. Middle East & Africa General Anaesthesia Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 50. Middle East & Africa General Anaesthesia Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 51. Middle East & Africa General Anaesthesia Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 52. Baxter International Company Detail
Table 53. Baxter International Business Overview
Table 54. Baxter International General Anaesthesia Drugs Product
Table 55. Baxter International Revenue in General Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 56. Baxter International Recent Development
Table 57. AstraZeneca Company Detail
Table 58. AstraZeneca Business Overview
Table 59. AstraZeneca General Anaesthesia Drugs Product
Table 60. AstraZeneca Revenue in General Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 61. AstraZeneca Recent Development
Table 62. Abbott Laboratories Company Detail
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories General Anaesthesia Drugs Product
Table 65. Abbott Laboratories Revenue in General Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. Roche Company Detail
Table 68. Roche Business Overview
Table 69. Roche General Anaesthesia Drugs Product
Table 70. Roche Revenue in General Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 71. Roche Recent Development
Table 72. Fresenius Company Detail
Table 73. Fresenius Business Overview
Table 74. Fresenius General Anaesthesia Drugs Product
Table 75. Fresenius Revenue in General Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 76. Fresenius Recent Development
Table 77. Mylan Company Detail
Table 78. Mylan Business Overview
Table 79. Mylan General Anaesthesia Drugs Product
Table 80. Mylan Revenue in General Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Eisai Company Detail
Table 83. Eisai Business Overview
Table 84. Eisai General Anaesthesia Drugs Product
Table 85. Eisai Revenue in General Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 86. Eisai Recent Development
Table 87. Hospira Company Detail
Table 88. Hospira Business Overview
Table 89. Hospira General Anaesthesia Drugs Product
Table 90. Hospira Revenue in General Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 91. Hospira Recent Development
Table 92. Hikma Pharmaceuticals Company Detail
Table 93. Hikma Pharmaceuticals Business Overview
Table 94. Hikma Pharmaceuticals General Anaesthesia Drugs Product
Table 95. Hikma Pharmaceuticals Revenue in General Anaesthesia Drugs Business (2019-2024) & (US$ Million)
Table 96. Hikma Pharmaceuticals Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global General Anaesthesia Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global General Anaesthesia Drugs Market Share by Type: 2023 VS 2030
Figure 3. Propofol Features
Figure 4. Sevoflurane Features
Figure 5. Isoflurane Features
Figure 6. Dexmedetomidine Features
Figure 7. Desflurane Features
Figure 8. Remifentanil Features
Figure 9. Midazolam Features
Figure 10. Others Features
Figure 11. Global General Anaesthesia Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global General Anaesthesia Drugs Market Share by Application: 2023 VS 2030
Figure 13. Hospitals Case Studies
Figure 14. Clinics Case Studies
Figure 15. Others Case Studies
Figure 16. General Anaesthesia Drugs Report Years Considered
Figure 17. Global General Anaesthesia Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global General Anaesthesia Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global General Anaesthesia Drugs Market Share by Region: 2023 VS 2030
Figure 20. Global General Anaesthesia Drugs Market Share by Players in 2023
Figure 21. Global Top General Anaesthesia Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Anaesthesia Drugs as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by General Anaesthesia Drugs Revenue in 2023
Figure 23. North America General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America General Anaesthesia Drugs Market Share by Country (2019-2030)
Figure 25. United States General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe General Anaesthesia Drugs Market Share by Country (2019-2030)
Figure 29. Germany General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific General Anaesthesia Drugs Market Share by Region (2019-2030)
Figure 37. China General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America General Anaesthesia Drugs Market Share by Country (2019-2030)
Figure 45. Mexico General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa General Anaesthesia Drugs Market Share by Country (2019-2030)
Figure 49. Turkey General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia General Anaesthesia Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Baxter International Revenue Growth Rate in General Anaesthesia Drugs Business (2019-2024)
Figure 52. AstraZeneca Revenue Growth Rate in General Anaesthesia Drugs Business (2019-2024)
Figure 53. Abbott Laboratories Revenue Growth Rate in General Anaesthesia Drugs Business (2019-2024)
Figure 54. Roche Revenue Growth Rate in General Anaesthesia Drugs Business (2019-2024)
Figure 55. Fresenius Revenue Growth Rate in General Anaesthesia Drugs Business (2019-2024)
Figure 56. Mylan Revenue Growth Rate in General Anaesthesia Drugs Business (2019-2024)
Figure 57. Eisai Revenue Growth Rate in General Anaesthesia Drugs Business (2019-2024)
Figure 58. Hospira Revenue Growth Rate in General Anaesthesia Drugs Business (2019-2024)
Figure 59. Hikma Pharmaceuticals Revenue Growth Rate in General Anaesthesia Drugs Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
